410 related articles for article (PubMed ID: 18079493)
41. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
42. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
43. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Daniels JM; Snijders D; de Graaff CS; Vlaspolder F; Jansen HM; Boersma WG
Am J Respir Crit Care Med; 2010 Jan; 181(2):150-7. PubMed ID: 19875685
[TBL] [Abstract][Full Text] [Related]
44. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Wilkinson TM; Patel IS; Wilks M; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2003 Apr; 167(8):1090-5. PubMed ID: 12684248
[TBL] [Abstract][Full Text] [Related]
45. Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.
Chang C; Zhu H; Shen N; Chen Y; He B; Zhao J; Yao W
COPD; 2015 Feb; 12(1):19-30. PubMed ID: 24800883
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
47. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis.
Gompertz S; O'Brien C; Bayley DL; Hill SL; Stockley RA
Eur Respir J; 2001 Jun; 17(6):1112-9. PubMed ID: 11491152
[TBL] [Abstract][Full Text] [Related]
48. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.
Moermans C; Heinen V; Nguyen M; Henket M; Sele J; Manise M; Corhay JL; Louis R
Cytokine; 2011 Nov; 56(2):298-304. PubMed ID: 21880505
[TBL] [Abstract][Full Text] [Related]
49. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
[TBL] [Abstract][Full Text] [Related]
50. [Exacerbations of chronic obstructive pulmonary disease and the role of sputum bacteriological examination].
Noweta K; Frankowska M; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2006; 74(4):396-402. PubMed ID: 17427149
[TBL] [Abstract][Full Text] [Related]
51. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
52. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
53. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease.
Sethi S; Wrona C; Grant BJ; Murphy TF
Am J Respir Crit Care Med; 2004 Feb; 169(4):448-53. PubMed ID: 14597486
[TBL] [Abstract][Full Text] [Related]
54. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
Alamoudi OS
Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464
[TBL] [Abstract][Full Text] [Related]
55. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.
Zhang M; Li Q; Zhang XY; Ding X; Zhu D; Zhou X
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1487-93. PubMed ID: 20725845
[TBL] [Abstract][Full Text] [Related]
56. Increased systemic inflammation is a risk factor for COPD exacerbations.
Groenewegen KH; Postma DS; Hop WC; Wielders PL; Schlösser NJ; Wouters EF;
Chest; 2008 Feb; 133(2):350-7. PubMed ID: 18198263
[TBL] [Abstract][Full Text] [Related]
57. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.
Daniels JM; de Graaff CS; Vlaspolder F; Snijders D; Jansen HM; Boersma WG
Clin Microbiol Infect; 2010 Jun; 16(6):583-8. PubMed ID: 19681947
[TBL] [Abstract][Full Text] [Related]
58. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
59. Association of COPD exacerbation frequency with gene expression of pattern recognition receptors in inflammatory cells in induced sputum.
Kinose D; Ogawa E; Kudo M; Marumo S; Kiyokawa H; Hoshino Y; Hirai T; Chin K; Muro S; Mishima M
Clin Respir J; 2016 Jan; 10(1):11-21. PubMed ID: 24902764
[TBL] [Abstract][Full Text] [Related]
60. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
